ABBV vs CI
By Alex · Tickerpine
AbbVie Inc. vs The Cigna Group, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | CI |
|---|---|---|
| Price | $266.28 | $271.83 |
| Market cap | $470.55B | $71.83B |
| P/E ratio | 75.0 | 11.2 |
| ROE | — | 16.76% |
| Profit margin | 9.80% | 2.27% |
| Revenue growth | 10.20% | 6.70% |
| Dividend yield | 2.62% | 2.30% |
| Beta | 0.28 | 0.32 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs CI in plain English
- ABBV is the bigger company — about 6.6× the market cap of CI.
- CI is cheaper on earnings (P/E 11.2 vs 75.0).
- ABBV is growing revenue faster (10% vs 7%).
- ABBV has the higher dividend yield (2.62% vs 2.30%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
CI return calculator
See what $1,000 in The Cigna Group would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.